Additional information
Pale yellow Powder
2518153-95-0
ACI-020813
75.0-76.2°C
C11H12BrN3
266.14
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
N-propylamino-5-bromoquinoxaline
6-(2-imidazoline-2-ylidineamino)-1,2,3,4-tetrahydroquinoxalin-2,3-dione
2-Quinoxalinamine, 5-bromo-N-propyl





![DESACETYL PALBOCICLIB HYDROCHLORIDE (25 mg) (8-Cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride (1:1))](https://staging.analyticachemie.in/wp-content/uploads/uspimage-1.jpg)